CROCS INC (CROX) Fundamental Analysis & Valuation

NASDAQ:CROX • US2270461096

Current stock price

84.15 USD
+1.13 (+1.36%)
Last:

This CROX fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

6

1. CROX Profitability Analysis

1.1 Basic Checks

  • In the past year CROX was profitable.
  • In the past year CROX had a positive cash flow from operations.
  • CROX had positive earnings in 4 of the past 5 years.
  • Each year in the past 5 years CROX had a positive operating cash flow.
CROX Yearly Net Income VS EBIT VS OCF VS FCFCROX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500M -500M 1B -1B -1.5B

1.2 Ratios

  • CROX has a worse Return On Assets (-1.94%) than 64.44% of its industry peers.
  • CROX has a worse Return On Equity (-6.28%) than 66.67% of its industry peers.
  • CROX has a better Return On Invested Capital (20.18%) than 91.11% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for CROX is significantly above the industry average of 11.58%.
Industry RankSector Rank
ROA -1.94%
ROE -6.28%
ROIC 20.18%
ROA(3y)11.62%
ROA(5y)18.77%
ROE(3y)33.33%
ROE(5y)1062.57%
ROIC(3y)20.49%
ROIC(5y)25.32%
CROX Yearly ROA, ROE, ROICCROX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1K 2K 3K 4K 5K

1.3 Margins

  • The Operating Margin of CROX (21.97%) is better than 95.56% of its industry peers.
  • CROX's Operating Margin has improved in the last couple of years.
  • With a decent Gross Margin value of 58.33%, CROX is doing good in the industry, outperforming 75.56% of the companies in the same industry.
  • CROX's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 21.97%
PM (TTM) N/A
GM 58.33%
OM growth 3Y-3.7%
OM growth 5Y4.08%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.69%
GM growth 5Y1.52%
CROX Yearly Profit, Operating, Gross MarginsCROX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

6

2. CROX Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so CROX is creating value.
  • The number of shares outstanding for CROX has been reduced compared to 1 year ago.
  • The number of shares outstanding for CROX has been reduced compared to 5 years ago.
  • CROX has a worse debt/assets ratio than last year.
CROX Yearly Shares OutstandingCROX Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M
CROX Yearly Total Debt VS Total AssetsCROX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B

2.2 Solvency

  • CROX has an Altman-Z score of 3.76. This indicates that CROX is financially healthy and has little risk of bankruptcy at the moment.
  • With a decent Altman-Z score value of 3.76, CROX is doing good in the industry, outperforming 73.33% of the companies in the same industry.
  • CROX has a debt to FCF ratio of 1.87. This is a very positive value and a sign of high solvency as it would only need 1.87 years to pay back of all of its debts.
  • The Debt to FCF ratio of CROX (1.87) is better than 82.22% of its industry peers.
  • CROX has a Debt/Equity ratio of 0.95. This is a neutral value indicating CROX is somewhat dependend on debt financing.
  • The Debt to Equity ratio of CROX (0.95) is worse than 73.33% of its industry peers.
  • Although CROX's pure debt/equity ratio does not look good, it has limited outstanding debt compared to the Free Cash Flow. We will not put too much weight on the debt/equity number as it may be because of low equity, which could be a consequence of a share buyback program for instance. This needs to be investigated.
Industry RankSector Rank
Debt/Equity 0.95
Debt/FCF 1.87
Altman-Z 3.76
ROIC/WACC1.99
WACC10.16%
CROX Yearly LT Debt VS Equity VS FCFCROX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1B -1B 2B

2.3 Liquidity

  • CROX has a Current Ratio of 1.27. This is a normal value and indicates that CROX is financially healthy and should not expect problems in meeting its short term obligations.
  • CROX has a Current ratio of 1.27. This is amonst the worse of the industry: CROX underperforms 86.67% of its industry peers.
  • A Quick Ratio of 0.74 indicates that CROX may have some problems paying its short term obligations.
  • CROX's Quick ratio of 0.74 is on the low side compared to the rest of the industry. CROX is outperformed by 86.67% of its industry peers.
Industry RankSector Rank
Current Ratio 1.27
Quick Ratio 0.74
CROX Yearly Current Assets VS Current LiabilitesCROX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. CROX Growth Analysis

3.1 Past

  • The earnings per share for CROX have decreased by -5.40% in the last year.
  • The Earnings Per Share has been growing by 30.96% on average over the past years. This is a very strong growth
  • Looking at the last year, CROX shows a decrease in Revenue. The Revenue has decreased by -1.50% in the last year.
  • CROX shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 23.86% yearly.
EPS 1Y (TTM)-5.4%
EPS 3Y4.47%
EPS 5Y30.96%
EPS Q2Q%-9.13%
Revenue 1Y (TTM)-1.5%
Revenue growth 3Y4.36%
Revenue growth 5Y23.86%
Sales Q2Q%-3.25%

3.2 Future

  • CROX is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 5.01% yearly.
  • The Revenue is expected to grow by 3.35% on average over the next years.
EPS Next Y9.08%
EPS Next 2Y7.83%
EPS Next 3Y5.36%
EPS Next 5Y5.01%
Revenue Next Year0.91%
Revenue Next 2Y1.69%
Revenue Next 3Y1.07%
Revenue Next 5Y3.35%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
CROX Yearly Revenue VS EstimatesCROX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 1B 2B 3B 4B
CROX Yearly EPS VS EstimatesCROX Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 0 5 10 15

More info and screens

Find the best growth stocksShow best growing peers

9

4. CROX Valuation Analysis

4.1 Price/Earnings Ratio

  • CROX is valuated cheaply with a Price/Earnings ratio of 6.76.
  • CROX's Price/Earnings ratio is rather cheap when compared to the industry. CROX is cheaper than 93.33% of the companies in the same industry.
  • Compared to an average S&P500 Price/Earnings ratio of 25.58, CROX is valued rather cheaply.
  • The Price/Forward Earnings ratio is 6.20, which indicates a rather cheap valuation of CROX.
  • 95.56% of the companies in the same industry are more expensive than CROX, based on the Price/Forward Earnings ratio.
  • The average S&P500 Price/Forward Earnings ratio is at 22.81. CROX is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 6.76
Fwd PE 6.2
CROX Price Earnings VS Forward Price EarningsCROX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • CROX's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. CROX is cheaper than 93.33% of the companies in the same industry.
  • Based on the Price/Free Cash Flow ratio, CROX is valued cheaply inside the industry as 93.33% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 6.41
EV/EBITDA 5.45
CROX Per share dataCROX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60 80

4.3 Compensation for Growth

  • CROX's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • The decent profitability rating of CROX may justify a higher PE ratio.
PEG (NY)0.74
PEG (5Y)0.22
EPS Next 2Y7.83%
EPS Next 3Y5.36%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. CROX Dividend Analysis

5.1 Amount

  • CROX does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

CROX Fundamentals: All Metrics, Ratios and Statistics

CROCS INC

NASDAQ:CROX (4/1/2026, 3:12:00 PM)

84.15

+1.13 (+1.36%)

Chartmill FA Rating
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryTextiles, Apparel & Luxury Goods
Earnings (Last)02-12
Earnings (Next)05-06
Inst Owners100.67%
Inst Owner Change-3.11%
Ins Owners2.89%
Ins Owner Change9.11%
Market Cap4.23B
Revenue(TTM)4.04B
Net Income(TTM)-81.20M
Analysts71.82
Price Target104.82 (24.56%)
Short Float %7.58%
Short Ratio2.77
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)19.66%
Min EPS beat(2)18.22%
Max EPS beat(2)21.1%
EPS beat(4)4
Avg EPS beat(4)15.32%
Min EPS beat(4)3.5%
Max EPS beat(4)21.1%
EPS beat(8)8
Avg EPS beat(8)15.96%
EPS beat(12)12
Avg EPS beat(12)14.53%
EPS beat(16)16
Avg EPS beat(16)15.58%
Revenue beat(2)2
Avg Revenue beat(2)1.95%
Min Revenue beat(2)1.48%
Max Revenue beat(2)2.42%
Revenue beat(4)3
Avg Revenue beat(4)0.99%
Min Revenue beat(4)-1.17%
Max Revenue beat(4)2.42%
Revenue beat(8)5
Avg Revenue beat(8)0.91%
Revenue beat(12)7
Avg Revenue beat(12)0.59%
Revenue beat(16)10
Avg Revenue beat(16)0.81%
PT rev (1m)12.72%
PT rev (3m)12.72%
EPS NQ rev (1m)1.1%
EPS NQ rev (3m)11.07%
EPS NY rev (1m)11.36%
EPS NY rev (3m)11.28%
Revenue NQ rev (1m)-0.03%
Revenue NQ rev (3m)0.21%
Revenue NY rev (1m)0.22%
Revenue NY rev (3m)1.38%
Valuation
Industry RankSector Rank
PE 6.76
Fwd PE 6.2
P/S 1.05
P/FCF 6.41
P/OCF 5.95
P/B 3.27
P/tB N/A
EV/EBITDA 5.45
EPS(TTM)12.44
EY14.78%
EPS(NY)13.57
Fwd EY16.13%
FCF(TTM)13.12
FCFY15.6%
OCF(TTM)14.14
OCFY16.81%
SpS80.44
BVpS25.75
TBVpS-8.68
PEG (NY)0.74
PEG (5Y)0.22
Graham Number84.89
Profitability
Industry RankSector Rank
ROA -1.94%
ROE -6.28%
ROCE 25.55%
ROIC 20.18%
ROICexc 20.97%
ROICexgc 43.42%
OM 21.97%
PM (TTM) N/A
GM 58.33%
FCFM 16.31%
ROA(3y)11.62%
ROA(5y)18.77%
ROE(3y)33.33%
ROE(5y)1062.57%
ROIC(3y)20.49%
ROIC(5y)25.32%
ROICexc(3y)21.34%
ROICexc(5y)28.15%
ROICexgc(3y)55.47%
ROICexgc(5y)57.23%
ROCE(3y)25.94%
ROCE(5y)32.05%
ROICexgc growth 3Y-10.15%
ROICexgc growth 5Y7.53%
ROICexc growth 3Y3.65%
ROICexc growth 5Y-5.95%
OM growth 3Y-3.7%
OM growth 5Y4.08%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.69%
GM growth 5Y1.52%
F-Score5
Asset Turnover0.97
Health
Industry RankSector Rank
Debt/Equity 0.95
Debt/FCF 1.87
Debt/EBITDA 1.27
Cap/Depr 64.62%
Cap/Sales 1.27%
Interest Coverage 11.43
Cash Conversion 73.47%
Profit Quality N/A
Current Ratio 1.27
Quick Ratio 0.74
Altman-Z 3.76
F-Score5
WACC10.16%
ROIC/WACC1.99
Cap/Depr(3y)125.61%
Cap/Depr(5y)1207.8%
Cap/Sales(3y)1.96%
Cap/Sales(5y)13.76%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-5.4%
EPS 3Y4.47%
EPS 5Y30.96%
EPS Q2Q%-9.13%
EPS Next Y9.08%
EPS Next 2Y7.83%
EPS Next 3Y5.36%
EPS Next 5Y5.01%
Revenue 1Y (TTM)-1.5%
Revenue growth 3Y4.36%
Revenue growth 5Y23.86%
Sales Q2Q%-3.25%
Revenue Next Year0.91%
Revenue Next 2Y1.69%
Revenue Next 3Y1.07%
Revenue Next 5Y3.35%
EBIT growth 1Y-15.14%
EBIT growth 3Y0.5%
EBIT growth 5Y28.92%
EBIT Next Year10.94%
EBIT Next 3Y2.54%
EBIT Next 5Y8.54%
FCF growth 1Y-28.59%
FCF growth 3YN/A
FCF growth 5Y24%
OCF growth 1Y-28.42%
OCF growth 3Y5.61%
OCF growth 5Y21.63%

CROCS INC / CROX Fundamental Analysis FAQ

What is the ChartMill fundamental rating of CROCS INC (CROX) stock?

ChartMill assigns a fundamental rating of 6 / 10 to CROX.


What is the valuation status of CROCS INC (CROX) stock?

ChartMill assigns a valuation rating of 9 / 10 to CROCS INC (CROX). This can be considered as Undervalued.


How profitable is CROCS INC (CROX) stock?

CROCS INC (CROX) has a profitability rating of 6 / 10.


Can you provide the PE and PB ratios for CROX stock?

The Price/Earnings (PE) ratio for CROCS INC (CROX) is 6.76 and the Price/Book (PB) ratio is 3.27.


Can you provide the financial health for CROX stock?

The financial health rating of CROCS INC (CROX) is 6 / 10.